10 February 2022

Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

On 9 February 2022, the Luxembourg Parliament has approved a new law amending the law of 22 March 2004 on securitisation. The new law will enter into force after publication in the official journal, which should occur in the course of February.

The new legislation has successfully implemented the feedback from market participants. Although the Luxembourg legal framework has proven so far to be sound and well-functioning, the new framework can even further increase the number of securitisation transactions using Luxembourg vehicles. Key changes include the diversification of financing instruments, active management of CDOs/CLOs and adjustments to the corporate governance of the securitisation framework.

The GSK Update provides a detailed overview of the new legal framework.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Andreas Heinzmann, LL.M.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Valerio Scollo, LL.M.

Local Partner

+352 271802-32

valerio.scollo@gsk-lux.com

Dr. Manuel Fernandez

Local Partner

+352 271802-31

manuel.fernandez@gsk-lux.com

Julia Kaalikoski, LL.M.

Associate

+352 271802-361

julia.kaalikoski@gsk-lux.com

© GSK Stockmann 2022